Prestige Consumer Healthcare (PBH) Operating Expenses (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Operating Expenses came in at $74.9 million in Q4 2025, up 8.38% year-on-year from $69.1 million in Q4 2024, and up 4.13% quarter-over-quarter from $71.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Operating Expenses (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Operating Expenses history runs 16 years deep, the most recent figure standing at $74.9 million for Q4 2025.
- On a quarterly basis, Operating Expenses rose 8.38% year-over-year to $74.9 million in Q4 2025; TTM through Dec 2025 was $296.9 million, a 3.91% increase from a year earlier, with the FY2025 full-year figure at $297.7 million, up 5.56% from the prior year.
- Operating Expenses grew to $74.9 million in Q4 2025 per PBH's latest filing, from $71.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $434.8 million in Q1 2023 and bottomed at $63.2 million in Q4 2022.
- The 5-year median for Operating Expenses is $71.8 million (2023), against an average of $90.0 million.
- Across the five-year window, Operating Expenses soared 508.59% in 2023 and slumped 83.98% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $72.5 million in 2021, then declined by 12.76% to $63.2 million in 2022, then grew by 12.48% to $71.1 million in 2023, then retreated by 2.84% to $69.1 million in 2024, then increased by 8.38% to $74.9 million in 2025.
- Per Business Quant, the three latest PBH Operating Expenses figures stand at $74.9 million (Q4 2025), $71.9 million (Q3 2025), and $68.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 74.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.88 Mn |
| Sep 30, 2025 | 71.91 Mn |
| Jun 30, 2025 | 68.58 Mn |
| Mar 31, 2025 | 81.58 Mn |
| Dec 31, 2024 | 69.09 Mn |
| Sep 30, 2024 | 73.04 Mn |
| Jun 30, 2024 | 73.98 Mn |
| Mar 31, 2024 | 69.66 Mn |
| Dec 31, 2023 | 71.11 Mn |
| Sep 30, 2023 | 71.77 Mn |
| Jun 30, 2023 | 69.48 Mn |
| Mar 31, 2023 | 434.76 Mn |
| Dec 31, 2022 | 63.22 Mn |
| Sep 30, 2022 | 76.63 Mn |
| Jun 30, 2022 | 73.11 Mn |
| Mar 31, 2022 | 71.44 Mn |
| Dec 31, 2021 | 72.47 Mn |
| Sep 30, 2021 | 79.15 Mn |
| Jun 30, 2021 | 67.67 Mn |
| Mar 31, 2021 | 66.12 Mn |